Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alfama

2005 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of small-molecule drugs intended to meet the unmet medical needs. The company's small-molecule drugs cure diseases and it focuses on carbon monoxide releasing molecules, enabling patients to get cure of their infectious and inflammatory diseases.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 955 Massachusetts Avenue
  • Suite 581
  • Cambridge, MA 02139
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alfama’s full profile, request a free trial.

Alfama Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 04-May-2017 Completed Out of Business
4. Out of Business 00.000 Completed Out of Business
3. Early Stage VC (Series A1) 30-May-2007 00.000 00.000 000.00 Completed Startup
2. Grant $2.57M $5.34M Completed Startup
1. Early Stage VC (Series A) 07-Jul-2005 $5.34M $5.34M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Alfama Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000,000 00.000000 00.00 00.00 00 00.00 0.00
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Alfama Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Strategic Reference Framework Other Minority 000 0000 000000 0
Portugal Capital Ventures Venture Capital Minority 000 0000 000000 0

Alfama Executive Team (5)

Name Title Board
Seat
Contact
Info
Nuno Arantes-Oliveira Ph.D President & Co-Founder

4 Former Executives

You’re viewing 1 of 5 executives. Get the full list »